NO145139C - Analogifremgangsmaate til fremstilling av terapeutisk aktive heteroarylbenzoksepin-eddiksyrer og estere herav - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive heteroarylbenzoksepin-eddiksyrer og estere herav

Info

Publication number
NO145139C
NO145139C NO762929A NO762929A NO145139C NO 145139 C NO145139 C NO 145139C NO 762929 A NO762929 A NO 762929A NO 762929 A NO762929 A NO 762929A NO 145139 C NO145139 C NO 145139C
Authority
NO
Norway
Prior art keywords
heteroarylbenzoxepin
esters
preparation
acetic acids
therapeutic active
Prior art date
Application number
NO762929A
Other languages
English (en)
Norwegian (no)
Other versions
NO762929L (de
NO145139B (no
Inventor
Arthur Raymond Mcfadden
Daniel Eugene Aultz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO762929L publication Critical patent/NO762929L/no
Publication of NO145139B publication Critical patent/NO145139B/no
Publication of NO145139C publication Critical patent/NO145139C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO762929A 1975-08-26 1976-08-25 Analogifremgangsmaate til fremstilling av terapeutisk aktive heteroarylbenzoksepin-eddiksyrer og estere herav NO145139C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/607,926 US4025640A (en) 1975-08-26 1975-08-26 Oxothienobenzoxepin-acetic acids, precursors and derivatives thereof

Publications (3)

Publication Number Publication Date
NO762929L NO762929L (de) 1977-03-01
NO145139B NO145139B (no) 1981-10-12
NO145139C true NO145139C (no) 1982-01-20

Family

ID=24434282

Family Applications (1)

Application Number Title Priority Date Filing Date
NO762929A NO145139C (no) 1975-08-26 1976-08-25 Analogifremgangsmaate til fremstilling av terapeutisk aktive heteroarylbenzoksepin-eddiksyrer og estere herav

Country Status (25)

Country Link
US (7) US4025640A (de)
JP (1) JPS5227764A (de)
AT (1) AT359505B (de)
AU (1) AU504461B2 (de)
BE (1) BE845551A (de)
CA (1) CA1068275A (de)
CH (1) CH624408A5 (de)
DE (1) DE2637110C3 (de)
DK (1) DK384576A (de)
ES (1) ES450881A1 (de)
FI (1) FI62093C (de)
FR (2) FR2346004A1 (de)
GB (2) GB1563841A (de)
GR (1) GR60832B (de)
HU (2) HU173465B (de)
IE (1) IE43940B1 (de)
IL (2) IL50347A (de)
IT (1) IT1064977B (de)
LU (1) LU75650A1 (de)
MX (1) MX4236E (de)
NL (1) NL7609292A (de)
NO (1) NO145139C (de)
PT (1) PT65513B (de)
SE (1) SE430161B (de)
ZA (1) ZA765112B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025640A (en) * 1975-08-26 1977-05-24 American Hoechst Corporation Oxothienobenzoxepin-acetic acids, precursors and derivatives thereof
US4104280A (en) * 1977-02-04 1978-08-01 Syntex (U.S.A.) Inc. Dibenzo [b.f]thiepin and dibenzo[b.f]oxepin derivatives
US4130654A (en) * 1978-01-30 1978-12-19 Syntex (U.S.A.) Inc. Novel 4-(8X-6,11-dihydrodibenzo-[b.e.]-thiepin-11-one-3-yl)-4-oxobutyric acids, methods of preparation, compositions and uses thereof
JPS54115388A (en) * 1978-03-01 1979-09-07 Nippon Chemiphar Co Ltd Acetic acid derivative and its preparation
JPS54147304U (de) * 1978-04-04 1979-10-13
US4211877A (en) * 1979-02-13 1980-07-08 American Hoechst Corporation Method of preparation of isopropyl 4,10-dihydro-10-oxothieno[3,2-c][1]benzoxepin-8-acetate
DE3125374A1 (de) * 1981-06-27 1983-01-13 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung von heteroaryl- und dibenzoxepinalkansaeuren
AU8509882A (en) * 1981-06-30 1983-01-06 Merck & Co., Inc. Tricyclic derivatives of substituted pyrrole acids
US4560701A (en) * 1981-07-23 1985-12-24 Hoechst-Roussel Pharmaceuticals Inc. Oxothienobenzoxepins, medicinal use, and process for the preparation thereof
US4496580A (en) * 1981-07-23 1985-01-29 Hoechst-Roussel Pharmaceuticals Inc. Oxothienobenzoxepins
US4751238A (en) * 1983-03-10 1988-06-14 Hoechst-Roussel Pharmaceuticals, Inc. Substituted alkyl amine derivatives of 6,11-dihydro-11-oxodibenz[b,e]oxepins
US4477465A (en) * 1983-03-10 1984-10-16 Hoechst-Roussel Pharmaceuticals Inc. Substituted 4,10-dihydro-10-oxothieno benzoxepins
EP0118867A3 (de) * 1983-03-10 1984-12-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituierte 4,10-Dihydro-10-oxothienobenzodiazepine, Methode zu ihrer Herstellung, Zwischenprodukte und ihre Anwendung als Arzneimittel
US4514411A (en) * 1983-03-10 1985-04-30 Hoechst-Roussel Pharmaceuticals Inc. Substituted 4,10-dihydro-10-oxothieno benzoxepins
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
US5139796A (en) * 1991-06-28 1992-08-18 Wm. Wrigley Jr. Company Tocopherol mixture for use as a mint oil antioxidant in chewing gum
US5132121A (en) * 1991-08-12 1992-07-21 Wm. Wrigley Jr. Company Gum base containing tocopherol
US5200213A (en) * 1991-08-12 1993-04-06 Wm. Wrigley Jr. Company Gum base containing tocopherol
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH83A (fr) * 1888-11-17 1889-01-10 Fontainemelon Horlogerie Perfectionnements apportés à la construction des montres de tous calibres
CH469729A (de) * 1963-08-31 1969-03-15 Spofa Vereinigte Pharma Werke Verfahren zur Herstellung von neuen 4,9-Dihydrothieno-(2,3-b)-benzo-(e)-thiepinderivaten
US3883551A (en) * 1969-08-25 1975-05-13 Little Inc A Thienobenzopyrans and thiopyranobenzopyrans
US3888946A (en) * 1971-03-17 1975-06-10 Little Inc A Pyrano benzopyrans
US3991194A (en) * 1971-12-27 1976-11-09 Sharps Associates Heterocyclic esters of benzopyranopyridines
US3960871A (en) * 1971-12-27 1976-06-01 Sharps Associates Esters of thienobenzopyrans and thiopyranobenzopyrans
DK131631C (da) * 1972-04-07 1976-01-12 Sandoz Ag Analogifremgangsmade til fremstilling af 4-oxo-benzo(4,5)cyclohepta(1,2-b)thiophen-2-eddikesyreforbindelser
GB1403487A (en) * 1972-07-21 1975-08-28 Yoshitomi Pharmaceutical Heterocyclic substituted alkanoic acids and derivatives
US3862143A (en) * 1972-12-04 1975-01-21 Warner Lambert Co Substituted chromone-3-carbonitriles, carboxamides and carboxylic acids
US3825574A (en) * 1972-12-04 1974-07-23 Warner Lambert Co Process for preparing substituted chromone-3-carbonitriles,carboxamides and carboxylic acids
US3895034A (en) * 1973-08-29 1975-07-15 Sharps Ass 1 OR 2-Mono and dialkyl substituted thienobenzopyrans
US3946111A (en) * 1973-08-29 1976-03-23 Sharps Associates Pharmaceutical compositions containing 1 or 2-mono and dialkyl substituted thienobenzopyrans and pharmacological uses thereof
FR2242098B1 (de) * 1973-09-04 1978-07-28 Yoshitomi Pharmaceutical
DK467274A (de) * 1973-09-13 1975-05-12 Sandoz Ag
US3952025A (en) * 1974-08-26 1976-04-20 American Hoechst Corporation Substituted 2-phenyl-4,6,7,8-tetrahydrofuro and 1,4,5,6,7,8-hexahydropyrrolo[3,2,-c]azepines
US4025640A (en) * 1975-08-26 1977-05-24 American Hoechst Corporation Oxothienobenzoxepin-acetic acids, precursors and derivatives thereof
US4028383A (en) * 1975-09-08 1977-06-07 Warner-Lambert Company Indolopyrones having antiallergic activity

Also Published As

Publication number Publication date
AT359505B (de) 1980-11-10
HU174164B (hu) 1979-11-28
DE2637110C3 (de) 1980-07-24
CH624408A5 (de) 1981-07-31
HU173465B (hu) 1979-05-28
IL58864A0 (en) 1980-03-31
ZA765112B (en) 1977-08-31
IE43940L (en) 1977-02-26
CA1068275A (en) 1979-12-18
US4107177A (en) 1978-08-15
MX4236E (es) 1982-02-24
ATA630876A (de) 1980-04-15
FR2346004A1 (fr) 1977-10-28
GR60832B (en) 1978-08-31
US4101559A (en) 1978-07-18
JPS5227764A (en) 1977-03-02
IE43940B1 (en) 1981-07-01
PT65513A (en) 1976-09-01
DE2637110B2 (de) 1979-10-11
IL50347A (en) 1982-04-30
GB1563841A (en) 1980-04-02
FR2351972A1 (fr) 1977-12-16
NO762929L (de) 1977-03-01
US4124713A (en) 1978-11-07
DE2637110A1 (de) 1977-03-17
NL7609292A (nl) 1977-03-01
IT1064977B (it) 1985-02-25
AU1715176A (en) 1978-03-02
FI762422A (de) 1977-02-27
NO145139B (no) 1981-10-12
BE845551A (fr) 1977-02-28
PT65513B (en) 1978-05-10
US4025640A (en) 1977-05-24
US4081457A (en) 1978-03-28
AU504461B2 (en) 1979-10-18
US4107321A (en) 1978-08-15
FI62093C (fi) 1982-11-10
IL50347A0 (en) 1976-10-31
US4117152A (en) 1978-09-26
ES450881A1 (es) 1977-12-16
FR2346004B1 (de) 1979-09-07
SE7609390L (sv) 1977-02-27
GB1563842A (en) 1980-04-02
FR2351972B1 (de) 1981-12-24
FI62093B (fi) 1982-07-30
DK384576A (da) 1977-02-27
LU75650A1 (de) 1977-04-27
SE430161B (sv) 1983-10-24

Similar Documents

Publication Publication Date Title
NO145139C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive heteroarylbenzoksepin-eddiksyrer og estere herav
SE423385B (sv) Forfarande for framstellning av cykloalitatiska aminosyror och estrar derav
NO803337L (no) Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme benzimidazolylacetohydroksamsyrer
NO146428C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive olefiniske derivater av aminosyrer
NO137321C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive 3-okso-17alfa-acyloksyandrost-4-en-17beta-karboksylsyreestere
NO146200C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 16-oksygenerte prostansyrederivater
NO143219C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO147104C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive acetylenderivater av aminosyrer
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO143796C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner
NO152005C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyrederivater
NO144926C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-benzazolylalkyl-4-substituerte piperidiner
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO147750C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive og optisk aktive 11-desoksy-16-aryloksy-omega-tetranorprostaglandiner
NO149737C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
NO152605C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-pyridyl- og 2-pyrimidylaminobenzoesyrer
NO145620C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive depotsteroidestere.
NO802277L (no) Fremgangsmaate til fremstilling av terapeutisk aktive 25-halocholest-5-en-3beta,22-dioler og estere derav
SE423097B (sv) Analogiforfarande for framstellning av apovinkaminoestrar
NO143502C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrano-kinolinkarboksylsyrer
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO143402C (no) Analogifremgangsmaate til fremstilling av et terapeutisk virksomt fenyleddiksyrederivat